tiprankstipranks
Trending News
More News >
Shanghai Fosun Pharmaceutical (Group) Co Class H (HK:2196)
:2196
Advertisement

Shanghai Fosun Pharmaceutical (Group) Co (2196) Price & Analysis

Compare
2 Followers

2196 Stock Chart & Stats


Shanghai Fosun Pharmaceutical (Group) Co News

2196 FAQ

What was Shanghai Fosun Pharmaceutical (Group) Co Class H’s price range in the past 12 months?
Shanghai Fosun Pharmaceutical (Group) Co Class H lowest stock price was HK$11.52 and its highest was HK$19.96 in the past 12 months.
    What is Shanghai Fosun Pharmaceutical (Group) Co Class H’s market cap?
    Shanghai Fosun Pharmaceutical (Group) Co Class H’s market cap is HK$72.87B.
      When is Shanghai Fosun Pharmaceutical (Group) Co Class H’s upcoming earnings report date?
      Shanghai Fosun Pharmaceutical (Group) Co Class H’s upcoming earnings report date is Aug 27, 2025 which is in 27 days.
        How were Shanghai Fosun Pharmaceutical (Group) Co Class H’s earnings last quarter?
        Shanghai Fosun Pharmaceutical (Group) Co Class H released its earnings results on Apr 30, 2025. The company reported HK$0.317 earnings per share for the quarter, missing the consensus estimate of HK$0.323 by -HK$0.005.
          Is Shanghai Fosun Pharmaceutical (Group) Co Class H overvalued?
          According to Wall Street analysts Shanghai Fosun Pharmaceutical (Group) Co Class H’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Shanghai Fosun Pharmaceutical (Group) Co Class H pay dividends?
            Shanghai Fosun Pharmaceutical (Group) Co Class H pays a Annually dividend of HK$0.35 which represents an annual dividend yield of 0.1%. See more information on Shanghai Fosun Pharmaceutical (Group) Co Class H dividends here
              What is Shanghai Fosun Pharmaceutical (Group) Co Class H’s EPS estimate?
              Shanghai Fosun Pharmaceutical (Group) Co Class H’s EPS estimate is 0.3.
                How many shares outstanding does Shanghai Fosun Pharmaceutical (Group) Co Class H have?
                Shanghai Fosun Pharmaceutical (Group) Co Class H has 551,940,500 shares outstanding.
                  What happened to Shanghai Fosun Pharmaceutical (Group) Co Class H’s price movement after its last earnings report?
                  Shanghai Fosun Pharmaceutical (Group) Co Class H reported an EPS of HK$0.317 in its last earnings report, missing expectations of HK$0.323. Following the earnings report the stock price went down -3.715%.
                    Which hedge fund is a major shareholder of Shanghai Fosun Pharmaceutical (Group) Co Class H?
                    Currently, no hedge funds are holding shares in HK:2196

                    Shanghai Fosun Pharmaceutical (Group) Co Stock Smart Score

                    Company Description

                    Shanghai Fosun Pharmaceutical (Group) Co Class H

                    Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, metabolism, alimentary and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.

                    Shanghai Fosun Pharmaceutical (Group) Co (2196) Earnings & Revenues

                    2196 Stock 12 Month Forecast

                    Average Price Target

                    HK$17.19
                    ▼(-11.02%Downside)
                    {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"12":"HK$12","15":"HK$15","18":"HK$18","21":"HK$21","24":"HK$24"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":17.1908974653,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$17.19</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":17.1908974653,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$17.19</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":17.1908974653,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$17.19</span>\n  </div></div>","useHTML":true}}],"tickPositions":[12,15,18,21,24],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2023","6":"Jul<br/>2023","9":"Oct<br/>2023","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.222,15.373453651176924,15.524907302353846,15.67636095353077,15.827814604707692,15.979268255884616,16.130721907061538,16.28217555823846,16.433629209415386,16.58508286059231,16.73653651176923,16.887990162946153,17.03944381412308,{"y":17.1908974653,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.222,15.373453651176924,15.524907302353846,15.67636095353077,15.827814604707692,15.979268255884616,16.130721907061538,16.28217555823846,16.433629209415386,16.58508286059231,16.73653651176923,16.887990162946153,17.03944381412308,{"y":17.1908974653,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.222,15.373453651176924,15.524907302353846,15.67636095353077,15.827814604707692,15.979268255884616,16.130721907061538,16.28217555823846,16.433629209415386,16.58508286059231,16.73653651176923,16.887990162946153,17.03944381412308,{"y":17.1908974653,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":23.432,"date":1672531200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.76,"date":1675209600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":21.979,"date":1677628800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.902,"date":1680307200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":21.417,"date":1682899200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":19.168,"date":1685577600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":19.589,"date":1688169600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":19.743,"date":1690848000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":17.692,"date":1693526400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":17.634,"date":1696118400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":17.634,"date":1696118400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":13.849,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":15.222,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    The United Laboratories International Holdings
                    Guangzhou Baiyunshan Pharmaceutical Holdings Company
                    Livzon Pharmaceutical Group
                    China Resources Pharmaceutical Group Ltd.
                    Grand Pharmaceutical Group Limited

                    Ownership Overview

                    3.46%94.66%
                    Insiders
                    3.46%
                    Mutual Funds
                    ― Other Institutional Investors
                    94.66% Public Companies and
                    Individual Investors

                    Options Prices

                    Currently, No data available
                    ---
                    Popular Stocks
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis